Autism Disorder In India – Present Scenario And Forecast -AcriIndia

1. Autism disorder is a developmental disorder that is characterized by repetitive behavior, communication challenges, and mote. Millions of people suffer from this disorder every year, which is only increasing year by year, and we don’t know where it will reach in the upcoming years. Till date, no cure has been found to the disorder. But, a number of treatments like speech therapy and behavioural therapy are being developed for the patients. Also, research and development is being done to make further treatments available in the market. Thus, there will be an expansion of the autism disorder and treatment market in the forthcoming years. As per the Market Research Future’s analysis, the global autism disorder and treatment market is expected to mark a CAGR of 4.37% during the period of 2017 to 2023. However, a weak pipeline for the drugs is expected to hinder the growth of the market. In January 2019, a bill had been advanced in Colorado to legalize the use of marijuana for treating autism. During the same time, a group of researchers in Japan also conducted a clinical trial to make available a drug as a nasal spray that can improve the symptoms of autism spectrum disorder. In addition, in Europe, the use of bumetanide had been evaluated to treat children suffering from autism.

2. Some of the key players outlined in the Market Research Future’s analysis include Pfizer Inc., Allergan, Merck & CO Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Novartis AG, Johnson & Johnson Services, Inc. Bristol-Myers Squibb and Otsuka Holdings Co., Ltd., Concern Pharma Private Limited, Coronis Partners Ltd., Heptares Therapeutics Limited, Curemark LLC, Intra-Cellular Therapies Inc., and Saniona AB. Segmentation The global autism disorder and treatment market has been segmented into Asperger Syndrome, Pervasive Developmental Disorder, and others, based on the type. Based in the treatment type, it has been segmented into applied behavioral analysis, hyperbaric oxygen therapy, chelation therapy, oxytocin therapy, and others. Based on the drug, it has been segmented into SSRIs, anti-convulsant, stimulants, anti- psychotic. Based on the region, it has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas has seen an upsurge in demand for autism screening tests due to the rising awareness, which may make it the largest regional autism disorder and treatment market globally in the future. Asia Pacific, on the other hand, has a significant proportion of autistic patients, but lesser awareness among the people for screening and treating the condition. But, with the rise in awareness, a favourable impact will be seen on the growth of the autism disorder and treatment market in the upcoming years. And, the Middle East and Africa regions, in the meantime, are likely to hold a small share of the market, but while exhibiting a steady growth. You can also lend a helping hand to your country to find treatments for many such incurable diseases by taking up clinical research as a serious profession. You can get enrolled at Avigna Clinical Research Institute to educate yourself with the professional clinical research courses in Bangalore that are taught by expert medical professors to give you complete knowledge about the field.